Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...

The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States ... troubled by the role of drug manufacturers” including Eli Lilly, Novo Nordisk and Sanofi that ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Eli Lilly and Company, Novo Nordisk and Sanofi, which the board in an executive summary refers to as “the Insulin Cartel,” control 99% of the insulin market. The suit also names pharmacy ...

"I had no warning," Juanita Gantt claims, adding that she now lives with an ileostomy bag CBS Mornings/YouTube A woman has filed a lawsuit against Novo Nordisk, the manufacturer of the popular ...

The 'big three' insulin producers Novo Nordisk, Eli Lilly ... The lawsuit also takes aim at the three largest pharmacy benefit managers (PBMs) in the US – CVS Caremark, Express Scripts, and ...

Lilly said the prices were in line with its current offering and a 50% discount to the list prices of competing products, including the popular Wegovy from Danish rival Novo Nordisk. U.S. Senator ...